bioRxivGenomicsPreprint
Computational prediction and analysis of very high risk single nucleotide polymorphisms in human cytochrome P450 oxidoreductase gene
D. D. BoscoiD, K. V. Rajalakshmi, S. SuganyaiD, P Pavani, Kaza Venkata Siva Yaswanth
Abstract
Cytochrome P450 oxidoreductase (POR) is a highly polymorphic gene which is involved in metabolism of drugs and steroids through transfer of electron from NADPH to all CYP enzymes. In this study, we attempt to identify the very high risk single nucleotide polymorphisms in POR gene that would affect phenotype of the enzyme. The genetic variants in POR gene were retrieved from databases and analyzed with appropriate online computation tools. Very high risk non-synonymous SNPs were identified with 12 different sequence and structure homology based tools and evolutionary conservation tool (Consurf). Further the phenotype effect of the variant was assessed with MutPred2 and LigPlot. The very high risk non-coding variants were predicted with HaploReg V4 and RegulomeDB tools. The very high risk SNPs that may affect miRNA target sites were screened using PolymiRTs v3.0, miRNA SNP v2.0 and MirSNP. Among 4,601 variants in POR gene, 58 missense variants, 8 non-coding variants and three SNPs in miRNA target sites were found to be very high risk. These very high risk variants may regulate the expression and activity of cytochrome P450 oxidoreductase enzyme leading to differential drug and steroid metabolism by CYP enzymes.
- organism: human
- assay: GWAS summary statistics
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Variability in Human Drug Metabolizing Cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 Activities Caused by Genetic Variations in Cytochrome P450 Oxidoreductase
M. N. R. Velazques, S. Parween, … A. V. Pandey·bioRxiv·May 17, 2019
- Loss of multiple enzyme activities due to the human genetic variation P284T in NADPH cytochrome P450 oxidoreductase
S. Parween, M. N. R. Velazquez, … A. V. Pandey·bioRxiv·May 20, 2019
- Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H
S. Parween, G. Di Nardo, … A. V. Pandey·bioRxiv·Oct 22, 2019
- Loss of protein stability and function caused by P228L variation in NADPH-cytochrome P450 reductase linked to lower testosterone levels.
M. N. R. Velazquez, M. Noebauer, A. V. Pandey·bioRxiv·Aug 16, 2022
- Benchmarking analysis of deleterious SNP prediction tools on CYP2D6 enzyme
Karla Cristina do Vale Ferreira, Leonardo Ferreira Fialho, … William Farias Porto·Chemical Biology & Drug DesignPeer-reviewed·Mar 9, 2020
- Across kingdom biased CYP-mediated metabolism via small-molecule ligands docking on P450 oxidoreductase
S. B. Jensen, S. Thodberg, … N. S. Hatzakis·bioRxiv·Sep 23, 2020